Spero Therapeutics, Inc.SPRONASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank80
5Y CAGR+31.5%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+31.5%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.27M | -31.8% |
| 2024 | $4.79M | +22.2% |
| 2023 | $3.92M | +193.0% |
| 2022 | $-4.22M | -136.3% |
| 2021 | $-1.78M | -314.3% |
| 2020 | $833000.00 | -63.6% |
| 2019 | $2.29M | +100.3% |
| 2018 | $1.14M | -38.0% |
| 2017 | $1.84M | +217.9% |
| 2016 | $580000.00 | - |